Page 83 - Demo

www.psypharma.ru %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 %u2116 4/2024%u041f%u0435%u0440%u0432%u0430%u044f %u0414.%u0412.83%u041f%u0420%u0410%u041a%u0422%u0418%u041a%u0410%u043b%u0438%u0442%u0435%u0440%u0430%u0442%u0443%u0440%u0430 References1. Schonecker M. Paroxysmal dyskinesia as the effect of megaphen // Nervenarzt. %u2013 1957. %u2013 Vol. 28 (12). %u2013 P%u0440. 550%u2013553.1. Schonecker M. Paroxysmal dyskinesia as the effect of megaphen // Nervenarzt. %u2013 1957. %u2013 Vol. 28 (12). %u2013 P%u0440. 550%u2013553.2. Sigwald J., Bouttier D., Raymondeaud C. Quatre cas de dyskinesie facio-bucco-linguomasticatrice a evelution prolongee secondaire a un traitement par les neuroleptiQues // Rev Neurol. %u2013 1959. %u2013 Vol. 100. %u2013 P%u0440. 751%u2013755.2. Sigwald J., Bouttier D., Raymondeaud C. Quatre cas de dyskinesie facio-bucco-linguomasticatrice a evelution prolongee secondaire a un traitement par les neuroleptiQues // Rev Neurol. %u2013 1959. %u2013 Vol. 100. %u2013 P%u0440. 751%u2013755.3. Wertheimer J. Syndromes extra-pyramidaux permanents cons%u0435%ue088cutifs %u0430` l%u2019administration prolong%u0435%ue088e de neuroleptiques: dissertation. %u2013 Universit%u0435%ue088 de Lausanne, Facult%u0435%ue088 de m%u0435%ue088decine, 1963.3. Wertheimer J. Syndromes extra-pyramidaux permanents cons%u0435%ue088cutifs %u0430` l%u2019administration prolong%u0435%ue088e de neuroleptiques: dissertation. %u2013 Universit%u0435%ue088 de Lausanne, Facult%u0435%ue088 de m%u0435%ue088decine, 1963.4. Savitt D., Jankovic J. Tardive syndromes // Journal of the neurological sciences. %u2013 2018. %u2013 Vol. 389. %u2013 P%u0440. 35%u201342. %u2013 https://doi.org/doi: 10.1016/j.jns.2018.02.0054. Savitt D., Jankovic J. Tardive syndromes // Journal of the neurological sciences. %u2013 2018. %u2013 Vol. 389. %u2013 P%u0440. 35%u201342. %u2013 https://doi.org/doi: 10.1016/j.jns.2018.02.0055. Salem H. et al. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management // Expert Review of Neurotherapeutics. %u2013 2017. %u2013 Vol. 17 (9). %u2013 P%u0440. 883%u2013894. %u2013 https://doi.org/10.1080/14737175.2017.13613225. Salem H. et al. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management // Expert Review of Neurotherapeutics. %u2013 2017. %u2013 Vol. 17 (9). %u2013 P%u0440. 883%u2013894. %u2013 https://doi.org/10.1080/14737175.2017.13613226. Crane G.E. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature // American Journal of Psychiatry. %u2013 1968. %u2013 Vol. 124 (8). %u2013 P%u0440. 40%u201348. %u2013 https://doi.org/10.1176/ajp.124.8S.406. Crane G.E. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature // American Journal of Psychiatry. %u2013 1968. %u2013 Vol. 124 (8). %u2013 P%u0440. 40%u201348. %u2013 https://doi.org/10.1176/ajp.124.8S.407. %u041c%u043e%u0441%u043e%u043b%u043e%u0432 %u0421.%u041d. %u041f%u0441%u0438%u0445%u043e%u0437%u044b %u0434%u043e%u0444%u0430%u043c%u0438%u043d%u043e%u0432%u043e%u0439 %u0433%u0438%u043f%u0435%u0440%u0447%u0443%u0432%u0441%u0442%u0432%u0438%u0442%u0435%u043b%u044c%u043d%u043e%u0441%u0442%u0438 %u043d%u0430 %u0441%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u043e%u043c %u044d%u0442%u0430%u043f%u0435 %u0430%u043d%u0442%u0438%u043f%u0441%u0438%u0445%u043e%u0442%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u0444%u0430%u0440%u043c%u0430%u043a%u043e%u0442%u0435%u0440%u0430%u043f%u0438%u0438 %u0448%u0438%u0437%u043e%u0444%u0440%u0435%u043d%u0438%u0438 : %u0447%u0442%u043e %u043d%u0443%u0436%u043d%u043e %u0437%u043d%u0430%u0442%u044c %u043f%u0440%u0430%u043a%u0442%u0438%u043a%u0443%u044e%u0449%u0435%u043c%u0443 %u0432%u0440%u0430%u0447%u0443 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2018. %u2013 %u2116 4. %u2013 %u0421. 41%u201349. %u2013 https://doi.org/10.21265/PSYPH.2018.47.217947. Mosolov S.N. Psihozy dofaminovoj giperchuvstvitel%u2019nosti na sovremennom jetape antipsihoticheskoj farmakoterapii shizofrenii : chto nuzhno znat%u2019 praktikujushhemu vrachu // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2018. %u2013 %u2116 4. %u2013 S. 41%u201349. %u2013 https://doi.org/10.21265/PSYPH.2018.47.217948. Baminiwatta A., Correll C.U. Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications // Frontiers in Psychiatry. %u2013 2023. %u2013 Vol. 14. %u2013 P%u0440. 1%u201344. %u2013 https://doi.org/10.3389/fpsyt.2023.11942228. Baminiwatta A., Correll C.U. Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications // Frontiers in Psychiatry. %u2013 2023. %u2013 Vol. 14. %u2013 P%u0440. 1%u201344. %u2013 https://doi.org/10.3389/fpsyt.2023.11942229. Chouinard G., Jones, D. B., Lawrence A. Neuroleptic-induced supersensitivity psychosis // Tardive Dyskinesia and Related Involuntary Movement Disorders. John Wright PSG of Boston, Massachusetts. %u2013 1978. %u2013 P%u0440. 109%u2013115.9. Chouinard G., Jones, D. B., Lawrence A. Neuroleptic-induced supersensitivity psychosis // Tardive Dyskinesia and Related Involuntary Movement Disorders. John Wright PSG of Boston, Massachusetts. %u2013 1978. %u2013 P%u0440. 109%u2013115.10. DSM-5 [Electronic resource]. URL: https://archive.org/stream/DSM5Eng/DSM@5%20eng_djvu.txt (accessed October 12, 2024).10. DSM-5 [Electronic resource]. URL: https://archive.org/stream/DSM5Eng/DSM@5%20eng_djvu.txt (accessed October 12, 2024).11. Frei K. Tardive dyskinesia: Who gets it and why // Parkinsonism and Related Disorders. %u2013 Vol. 59. %u2013 P%u0440. 151%u2013154. %u2013 https://doi.org/10.1016/j.parkreldis.2018.11.01711. Frei K. Tardive dyskinesia: Who gets it and why // Parkinsonism and Related Disorders. %u2013 Vol. 59. %u2013 P%u0440. 151%u2013154. %u2013 https://doi.org/10.1016/j.parkreldis.2018.11.01712. Carbon M., Hsieh C.H., Kane J. Tardive dyskinesia prevalence in the period of secondgeneration antipsychotic use: a meta-analysis // J Clin Psychiatry. %u2013 2017. %u2013 Vol. 78 (3). %u2013 Art. 20738. %u2013 https://doi.org/10.4088/JCP.16r1083212. Carbon M., Hsieh C.H., Kane J. Tardive dyskinesia prevalence in the period of secondgeneration antipsychotic use: a meta-analysis // J Clin Psychiatry. %u2013 2017. %u2013 Vol. 78 (3). %u2013 Art. 20738. %u2013 https://doi.org/10.4088/JCP.16r1083213. %u041f%u043e%u0442%u0430%u043d%u0438%u043d %u0421.%u0421., %u0410%u043d%u0442%u043e%u043d%u043e%u0432%u0438%u0447 %u0411.%u0410., %u0421%u0430%u0439%u0444%u0443%u043b%u0438%u043d%u0430 %u0410.%u041c. %u0410%u043b%u0433%u043e%u0440%u0438%u0442%u043c %u0431%u0438%u043e%u043b%u043e%u0433%u0438%u0447%u0435%u0441%u043a%u043e%u0439 %u0442%u0435%u0440%u0430%u043f%u0438%u0438 %u043f%u043e%u0437%u0434%u043d%u0435%u0439 %u0434%u0438%u0441%u043a%u0438%u043d%u0435%u0437%u0438%u0438 // %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430%u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430%u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432. %u2013 2021. %u2013 %u2116 4. %u2013 %u0421. 41%u201349. %u2013 https://doi.org/10.21265/PSYPH.2021.24.99.00513. Potanin S.S., Antonovich B.A., Sajfulina A.M. Algoritm biologicheskoj terapii pozdnej diskinezii // Sovremennaa Terapia Psihiceskih Rasstrojstv. %u2013 2021. %u2013 %u2116 4. %u2013 S. 41%u201349. %u2013 https://doi.org/10.21265/PSYPH.2021.24.99.00514. Jain R., Correll C.U. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis: (Academic Hightlights) // J Clin Psychiatry. %u2013 2018. %u2013 Vol. 79 (2). %u2013 P%u0440. 16%u201323. %u2013 https://doi.org/10.4088/JCP.nu17034ah1c14. Jain R., Correll C.U. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis: (Academic Hightlights) // J Clin Psychiatry. %u2013 2018. %u2013 Vol. 79 (2). %u2013 P%u0440. 16%u201323. %u2013 https://doi.org/10.4088/JCP.nu17034ah1c15. Widschwendter C.G., Hofer A. Antipsychotic-induced tardive dyskinesia: Update on epidemiology and management // Current Opinion in Psychiatry. %u2013 2019. %u2013 Vol. 32 (3). %u2013 P%u0440. 179%u2013184. %u2013 https://doi.org/10.1097/YCO.000000000000049115. Widschwendter C.G., Hofer A. Antipsychotic-induced tardive dyskinesia: Update on epidemiology and management // Current Opinion in Psychiatry. %u2013 2019. %u2013 Vol. 32 (3). %u2013 P%u0440. 179%u2013184. %u2013 https://doi.org/10.1097/YCO.000000000000049116. Jackson R. et al. Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia // Journal of Clinical Psychiatry. %u2013 2022. %u2013 Vol. 84 (1). %u2013 %u0420. 22cs14563. %u2013 https://doi.org/10.4088/JCP.22cs1456316. Jackson R. et al. Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia // Journal of Clinical Psychiatry. %u2013 2022. %u2013 Vol. 84 (1). %u2013 %u0420. 22cs14563. %u2013 https://doi.org/10.4088/JCP.22cs1456317. ICD-10 [Electronic resource]. URL: https://icd.who.int/browse10/2019/en (accessed October 12, 2024).17. ICD-10 [Electronic resource]. URL: https://icd.who.int/browse10/2019/en (accessed October 12, 2024).18. ICD-11 [Electronic resource]. URL: https://icd.who.int/en (accessed October 12, 2024). 18. ICD-11 [Electronic resource]. URL: https://icd.who.int/en (accessed October 12, 2024).19. Citrome L., Dufresne R., Dyrud J.M. Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders // The American Journal Of Managed Care. %u2013 2007. %u2013 P. 1-12.19. Citrome L., Dufresne R., Dyrud J.M. Tardive Dyskinesia: Minimizing Risk and Improving Outcomes in Schizophrenia and Other Disorders // The American Journal Of Managed Care. %u2013 2007. %u2013 P. 1-12.20. Keepers G.A. et al. The American psychiatric association practice guideline for the treatment of patients with schizophrenia // American Journal of Psychiatry. %u2013 2020. %u2013 Vol. 177 (9). %u2013 P%u0440. 868%u2013872. %u2013 https://doi.org/10.1176/appi.ajp.2020.17790120. Keepers G.A. et al. The American psychiatric association practice guideline for the treatment of patients with schizophrenia // American Journal of Psychiatry. %u2013 2020. %u2013 Vol. 177 (9). %u2013 P%u0440. 868%u2013872. %u2013 https://doi.org/10.1176/appi.ajp.2020.17790121. Lane R., Glazer W., Hansen T. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale // The Journal of Nervous and Mental disease. %u2013 1985. %u2013 Vol. 173 (6). %u2013 P%u0440. 353%u2013357. %u2013 https://doi.org/10.1097/00005053-198506000-0000521. Lane R., Glazer W., Hansen T. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale // The Journal of Nervous and Mental disease. %u2013 1985. %u2013 Vol. 173 (6). %u2013 P%u0440. 353%u2013357. %u2013 https://doi.org/10.1097/00005053-198506000-0000522. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia // Archives of General Psychiatry. %u2013 Vol. 39 (4). %u2013 1982. %u2013 P%u0440. 486%u2013487. %u2013https://doi.org/10.1001/archpsyc.1982.0429004008001422. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia // Archives of General Psychiatry. %u2013 Vol. 39 (4). %u2013 1982. %u2013 P%u0440. 486%u2013487. %u2013https://doi.org/10.1001/archpsyc.1982.0429004008001423. Carbon M. et al. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis // World Psychiatry. %u2013 2018. %u2013 Vol. 17 (3). %u2013 P%u0440. 330%u2013340. %u2013 https://doi.org/10.1002/wps.2057923. Carbon M. et al. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis // World Psychiatry. %u2013 2018. %u2013 Vol. 17 (3). %u2013 P%u0440. 330%u2013340. %u2013 https://doi.org/10.1002/wps.2057924. Patterson-Lomba O., Ayyagari R., Carroll B. Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: A retrospective data analysis // BMC Neurology. %u2013 2019. %u2013 Vol. 19 (1). %u2013 P%u0440. 1%u201310. %u2013https://doi.org/10.1186/s12883-019-1385-424. Patterson-Lomba O., Ayyagari R., Carroll B. Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: A retrospective data analysis // BMC Neurology. %u2013 2019. %u2013 Vol. 19 (1). %u2013 P%u0440. 1%u201310. %u2013https://doi.org/10.1186/s12883-019-1385-425. Solmi M. et al. Clinical risk factors for the development of tardive dyskinesia // Journal of the Neurological Sciences. %u2013 2018. %u2013 Vol. 389. %u2013 Pp. 21%u201327.25. Solmi M. et al. Clinical risk factors for the development of tardive dyskinesia // Journal of the Neurological Sciences. %u2013 2018. %u2013 Vol. 389. %u2013 Pp. 21%u201327.